Neurodegenerative Diseases: Studying protein aggregation using NanoTemper instruments

Neurodegenerative diseases like Alzheimer’s or Parkinson’s Disease affect millions of people worldwide. Although current treatments may help relieve some of the physical or mental symptoms, there is still no way to slow disease progression and no known cures. NanoTemper is committed to providing new solutions for studying these diseases and developing new treatments. This webinar will show how aggregation of intrinsically disordered proteins is a common characteristic of all neurodegenerative disorders and also how NanoTemper’s instruments can overcome the challenges of other technologies when studying them.

Previous Article
Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates
Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates

Up next
Prolyl oligopeptidase enhances alpha-syn dimerization
Prolyl oligopeptidase enhances alpha-syn dimerization

Characterize the molecular mechanisms of neurodegenerative diseases

Learn how